Skip to main content

Innoviva Inc(INVA-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Innoviva Inc

1350 OLD BAYSHORE HIGHWAY SUITE 400
BURLINGAME CA 94010 USA
P: 650-238-9600
http://www.inva.com

Profile

Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company's portfolio of respiratory assets partnered with Glaxo Group Limited, including RELVAR(R)/BREO(R) ELLIPTA(R) and ANORO(R) ELLIPTA(R). Innoviva, Inc., formerly known as Theravance, Inc., is headquartered in South San Francisco, California.

Key Executives

NameTitle
Marianne ZhenChief Accounting Officer
Pavel RaifeldCEO/Director
Stephen BassoCFO

More from The Globe

Insider Report: Chair sells $5-million from this stock yielding 5.8% that’s doubled in under a year
The Bay Street Financial District is shown with the Canadian flag in Toronto on Friday, August 5, 2022. THE CANADIAN PRESS/Nathan Denette
Canaccord reworks U.S. leadership in wake of regulatory settlement
The logo for Canaccord Genuity is shown in Toronto on Wednesday, March 8, 2023. THE CANADIAN PRESS/Staff
Bullish on FirstEnergy Corp.
Monica Rizk
The most oversold and overbought stocks on the TSX
The Bay Street Financial District is shown with the Canadian flag in Toronto on Friday, August 5, 2022.
Monday’s analyst upgrades and downgrades
A Dollarama store is seen Tuesday, June 11, 2013 in Montreal. Dollarama Inc. raised its quarterly dividend by 10 per cent as it reported its fourth-quarter profit and sales rose compared with a year ago. THE CANADIAN PRESS/Paul Chiasson
opinion
Why are Canadian bank valuations so low?
Tom Bradley
number cruncher
Eleven U.S. semiconductor stocks showing strength
For Number Cruncher column in Globe Investor/ROB only.
Wednesday’s analyst upgrades and downgrades
An office building for Goeasy Ltd, a personal lender for subprime borrowers, in Mississauga, Ontario, on March 10, 2026.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.